BioMed Research International / 2013 / Article / Tab 1

Clinical Study

Different Impact of Pretransplant Anti-HLA Antibodies Detected by Luminex in Highly Sensitized Renal Transplanted Patients

Table 1

Demographic and clinical characteristics.

Non-HSHS HS Pre-Tx DSAHS non-DSA

Donor
 Gender (% male)69%68%0.971%68%0.7
 Age (years, mean ± SD)40 ± 1539 ± 100.841 ± 1240 ± 80.8
Recipient
 Gender (% male)64%62%0.861.5%30%0.1
 Age (years, mean ± SD)50 ± 1344 ± 100.0343 ± 1244 ± 160.9
HLA mismatch (median, IQR)4 (3–5)4 (3–5)4 (3–5)4 (3–5)
Cold ischemia time (hours, mean ± SD)19 ± 518 ± 60.419 ± 517 ± 70.4
Delayed graft function (DGF)*62%65%0.767%63%0.5
Acute rejection (AR)33%57%0.0377%30%0.03
Death censored 1 year allograft survival96%78%0.00846%100%0.007

DGF was defined as the need for dialysis during the first week after transplant.

We are committed to sharing findings related to COVID-19 as quickly as possible. We will be providing unlimited waivers of publication charges for accepted research articles as well as case reports and case series related to COVID-19. Review articles are excluded from this waiver policy. Sign up here as a reviewer to help fast-track new submissions.